Stock Earnings

Question 1

How did ADAP's recent EPS compare to expectations?

Accepted Answer

The most recent EPS for Adaptimmune Therapeutics PLC is $-0.02, not beating expectations of $-0.1.

Question 2

How did Adaptimmune Therapeutics PLC ADAP's revenue perform in the last quarter?

Accepted Answer

Adaptimmune Therapeutics PLC revenue for the last quarter is $-0.02

Question 3

What is the revenue estimate for Adaptimmune Therapeutics PLC?

Accepted Answer

According to 4 of Wall street analyst, the revenue estimate of Adaptimmune Therapeutics PLC range from $2.1M to $1.96M

Question 4

What's the earning quality score for Adaptimmune Therapeutics PLC?

Accepted Answer

Adaptimmune Therapeutics PLC has a earning quality score of B+/51.519035. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.

Question 5

When does Adaptimmune Therapeutics PLC report earnings?

Accepted Answer

Adaptimmune Therapeutics PLC next earnings report is expected in 2025-11-11

Question 6

What are Adaptimmune Therapeutics PLC's expected earnings?

Accepted Answer

Adaptimmune Therapeutics PLC expected earnings is $10.23M, according to wall-street analysts.

Question 7

Did Adaptimmune Therapeutics PLC beat earnings expectations?

Accepted Answer

Adaptimmune Therapeutics PLC recent earnings of $13.67M beat expectations.

Fiscal Period	Estimated	Reported	Surprise	Result
Q2 '25	$-0.1	$-0.02	-80.0%	MISSED
Q1 '25	$-0.15	$-0.19	+26.66%	BEAT
Q4 '24	$-0.13	$-0.24	+84.61%	BEAT
Q3 '24	$-0.13	$-0.01	-92.3%	MISSED
Q2 '24	$-0.07	$0.24	-442.85%	MISSED

Adaptimmune Therapeutics PLC (ADAP) Price

ADAP Stock Price Chart

Latest Earnings Results: Q2 '25

Historical Earnings

Earnings FAQ